Morgan Stanley Assumes Medtronic, Inc. (MDT) at Overweight, 'More heartthrob than heartbreaker'

Go back to Morgan Stanley Assumes Medtronic, Inc. (MDT) at Overweight, 'More heartthrob than heartbreaker'

Medtronic, Inc. (MDT) PT Lowered to $90 at Truist Securities

May 26, 2023 7:14 AM EDT

Truist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $90.00 (from $93.00) while maintaining a Hold rating.... More

Medtronic, Inc. (MDT) PT Lowered to $99 at Bernstein

May 26, 2023 5:56 AM EDT

Bernstein analyst Lee Hambright lowered the price target on Medtronic, Inc. (NYSE: MDT) to $99.00 (from $100.00) while maintaining a Outperform rating.... More